The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2

Sex Transm Infect. 2011 Jun;87(4):301-5. doi: 10.1136/sti.2010.047142. Epub 2011 Mar 29.

Abstract

Background: In the context of a multisite HIV prevention trial in Southern African women, we examined the effectiveness of the Ortho All-Flex Diaphragm, lubricant gel (Replens) and condoms compared to condoms alone on the incidence of herpes simplex virus type 2 (HSV-2) infections.

Methods: We analysed data from 2016 sexually active women in Zimbabwe and South Africa. Women were followed quarterly, and specimens obtained at the closing visit from previously HSV-2 seronegative women were retested for HSV-2 antibodies using Focus HerpeSelect Elisa. The first visit at which the participant tested positive for HSV-2 was defined by back-testing. We compared the incidence of HSV-2 after randomisation between study arms in both intent-to-treat (ITT) and per-protocol populations.

Results: 210 women acquired HSV-2 during study participation (HSV incidence: 6.8 cases/100 women years). Allocation to the intervention arm was found to offer no benefit in reduction of HSV-2 by modified ITT (HR 1.03, 95% CI 0.78 to 1.35; p=0.85) or per protocol analysis (HR 0.87, 95% CI 0.61 to 1.24; p=0.45).

Conclusions: HSV-2 infection was common in the study population as detected by type-specific Elisa testing. Provision of diaphragm and lubricant gel offered no additional protection against HSV-2 acquisition over male condoms alone.

Trial registration: ClinicalTrials.gov NCT00121459.

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Condoms / statistics & numerical data
  • Contraceptive Devices, Female*
  • Female
  • Herpes Genitalis / prevention & control*
  • Herpesvirus 2, Human*
  • Humans
  • Lipids / administration & dosage
  • Lubricants / administration & dosage*
  • Middle Aged
  • Sexual Partners
  • South Africa
  • Young Adult
  • Zimbabwe

Substances

  • Lipids
  • Lubricants
  • Replens

Associated data

  • ClinicalTrials.gov/NCT00121459